Application of exocarpium citri rubrum expectoration extract in preparation of medicine for inhibiting human coronavirus infection

The invention belongs to the technical field of medicines, and particularly relates to application of exocarpium citri rubrum expectoration extract in preparation of a medicine for inhibiting human coronavirus infection. The invention provides application of exocarpium citri rubrum expectoration extract in preparation of the medicine for inhibiting human coronavirus infection, and experiments show that the exocarpium citri rubrum expectoration extract can inhibit mRNA overexpression of human coronavirus-induced inflammatory factors TNF-alpha, IL-6, IL-8 and IFN-alpha, so that the human coronavirus is inhibited..

Medienart:

Patent

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Europäisches Patentamt - (2021) vom: 17. Sept. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Beteiligte Personen:

SUN WEIGUANG [VerfasserIn]
GAO JIANSHENG [VerfasserIn]
WAN ANFENG [VerfasserIn]
ZHONG XIAOTIAN [VerfasserIn]
DU MANLING [VerfasserIn]
HUANG ZHIYUN [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2021-09-17, Last update posted on www.tib.eu: 2022-07-29, Last updated: 2023-02-09

Patentnummer:

CN113398219

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA012807842